Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Patched 1 protein is a transmembrane receptor and a key component of the Hedgehog (Hh) signaling pathway. It acts as a tumor suppressor by inhibiting Smoothened (SMO) in the absence of Hh ligands. Mutations in PTCH1 are associated with various developmental disorders and cancers.
Inhibits Smoothened (SMO) in the absence of Hedgehog ligands. Binding of Hedgehog ligands relieves this inhibition, activating downstream signaling.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Patched 1 Protein (PTCH1).